Prospective, multi‑center non-randomized single arm phase II study.

Trial Profile

Prospective, multi‑center non-randomized single arm phase II study.

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Nov 2017

At a glance

  • Drugs Sirolimus (Primary)
  • Indications Arteriovenous fistula
  • Focus Therapeutic Use
  • Sponsors Vascular Therapies
  • Most Recent Events

    • 17 Nov 2017 Results published in the Vascular Therapies company website (http://www.vasculartx.com/progress-to-date/)
    • 17 Nov 2017 New trial record
    • 09 Nov 2017 Results published in the Vascular Therapies media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top